Limited guidelines exist for IPG management. Specificity and adaptability to emerging technology are crucial. The findings highlight the need for specificity in patients' needs and adaptability to emerging technology in future studies. To address this need, we developed a protocol for DBS IPG management that we have implemented at our own institution. Further research is needed for effective DBS IPG battery life management, preventing therapy cessation complications.
Keyphrases
- deep brain stimulation
- parkinson disease
- end stage renal disease
- randomized controlled trial
- obsessive compulsive disorder
- ejection fraction
- newly diagnosed
- chronic kidney disease
- blood pressure
- peritoneal dialysis
- risk factors
- clinical practice
- current status
- mesenchymal stem cells
- patient reported outcomes
- bone marrow
- smoking cessation
- structural basis